Cargando…

Association of Blood Amyloid Beta-Protein 1-42 with Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis

BACKGROUND: Increases in blood of amyloid beta-protein (Aβ) have been noted in patients with Alzheimer's dementia (AD). Recent studies have shown that blood amyloid beta-protein 1-42 (Aβ1-42) level is closely related to poststroke cognitive impairment (PSCI), which may be the influencing factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hui, Gu, Sichun, Liu, Xiaoying, Xie, Anjie, Wang, Changde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986382/ https://www.ncbi.nlm.nih.gov/pubmed/35402621 http://dx.doi.org/10.1155/2022/6552781

Ejemplares similares

Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment
por: Yoon, Bora, et al.
Publicado: (2021)

Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018)

Impaired cerebral autoregulation is associated with poststroke cognitive impairment
por: Chi, Nai‐Fang, et al.
Publicado: (2020)

Effects of exercise therapy on patients with poststroke cognitive impairment: A systematic review and meta-analysis
por: Zhang, Yuanxing, et al.
Publicado: (2023)

Acupuncture-related therapies for the poststroke cognitive impairment patients: A protocol for systematic review and network meta-analysis
por: Tian, Jun, et al.
Publicado: (2022)

Amyloid beta-42 Levels in Companion Dog Brains Correlate with Age and Cognitive Function
por: Urfer, Silvan, et al.
Publicado: (2020)

High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1–42-induced Alzheimer's disease
por: Yu, Chao-Chao, et al.
Publicado: (2018)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
por: Maity, Sibaprasad, et al.
Publicado: (2020)

A systematic review of auricular therapy for poststroke cognitive impairment and dementia: A protocol for systematic review and meta-analysis
por: Gao, Zhaohong, et al.
Publicado: (2023)

Behavioural and Psychological Symptoms in Poststroke Vascular Cognitive Impairment
por: Gupta, Meena, et al.
Publicado: (2014)

Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatment
por: Melkas, Susanna, et al.
Publicado: (2014)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Amyloid-beta 42 adsorption following serial tube transfer
por: Toombs, Jamie, et al.
Publicado: (2014)

Midterm Blood Pressure Variability Is Associated with Poststroke Cognitive Impairment: A Prospective Cohort Study
por: Geng, Shan, et al.
Publicado: (2017)

Efficacy and Safety of DL-3-n-Butylphthalide in the Treatment of Poststroke Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Fan, Xueming, et al.
Publicado: (2022)

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
por: van Bergen, J. M. G., et al.
Publicado: (2016)

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
por: Melzer, Tracy R., et al.
Publicado: (2019)

Is postoperative cognitive decline after cardiac surgery associated with plasma beta amyloid 1–42 levels?
por: Požgain, Zrinka, et al.
Publicado: (2022)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
por: Sinclair, Patricia, et al.
Publicado: (2021)

HEARING IMPAIRMENT, COGNITIVE PERFORMANCE, AND BETA-AMYLOID DEPOSITION IN THE ARIC-PET AMYLOID IMAGING STUDY
por: Deal, Jennifer A, et al.
Publicado: (2019)

Medial Temporal Atrophy and Memory Dysfunction in Poststroke Cognitive Impairment-No Dementia
por: Kim, Beom Joon, et al.
Publicado: (2012)

Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups
por: Lo, Jessica W., et al.
Publicado: (2019)

Poststroke Cognitive Impairment Research Progress on Application of Brain-Computer Interface
por: Sun, Xiaowei, et al.
Publicado: (2022)

Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis
por: Liu, Yang, et al.
Publicado: (2019)

Comparison of Different Physical Therapies Combined with Acupuncture for Poststroke Cognitive Impairment: a Network Meta-Analysis
por: Li, Ruo-Yang, et al.
Publicado: (2021)

Effects of Combined Cognitive and Exercise Interventions on Poststroke Cognitive Function: A Systematic Review and Meta-Analysis
por: Sun, Ruifeng, et al.
Publicado: (2021)

Apathy, Cognitive Impairment, and Social Support Contribute to Participation in Cognitively Demanding Activities Poststroke
por: Ho, Amy, et al.
Publicado: (2021)

Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
por: Marshall, Karen E., et al.
Publicado: (2020)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β(1–42) Oligomers
por: Wang, Li-Sha, et al.
Publicado: (2019)

Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
por: Qu, Wensheng, et al.
Publicado: (2023)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

The Protective Effects of Zeaxanthin on Amyloid-β Peptide 1–42-Induced Impairment of Learning and Memory Ability in Rats
por: Li, Xiaoying, et al.
Publicado: (2022)

Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

The Role of Age on Beta-Amyloid(1–42) Plasma Levels in Healthy Subjects
por: Zecca, Chiara, et al.
Publicado: (2021)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2mjkodntqmafoesbd75jhi0d7